sTMS Device May Prevent Migraine

A study undertaken to evaluate the efficacy and tolerability of single pulse transcranial magnetic stimulation (sTMS) for the preventive treatment of migraine has led to an FDA extended indication.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.